HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹302 Cr | ₹280 Cr | ₹187 Cr | ₹315 Cr | ₹294 Cr |
What is the latest Cash Flow from Operating Activities ratio of HIKAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹302 Cr |
| Mar2025 | ₹280 Cr |
| Mar2024 | ₹187 Cr |
| Mar2023 | ₹315 Cr |
| Mar2022 | ₹294 Cr |
How is Cash Flow from Operating Activities of HIKAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹302 Cr | 7.70 | |
| Mar2025 | ₹280 Cr | 50.19 | |
| Mar2024 | ₹187 Cr | -40.79 | |
| Mar2023 | ₹315 Cr | 7.35 | |
| Mar2022 | ₹294 Cr | - | |
Compare Cash Flow from Operating Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,753.9 Cr | -0.1% | 3% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.1% |
3% |
-9.3% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses